Glucose Health Inc. (GLUC)

[Altitrade Partners]

We beg to differ with you. An uplisting to NASDAQ, along with a reverse split, is necessary to move the company forward.

Without capital, Murray cannot expand distribution, since it takes money to produce inventory and new innovative products.

The OTC Market has changed dramatically, for pink sheet companies, as result of SEC Rule 15c2-11. It has made it almost impossible for pink sheet companies to raise capital, since just about every broker/dealer refuses to custody the restricted shares of (SEC) non-reporting companies whose share price is below $5.

Almost every private placement that these types of companies (pink sheet) engage in will result in the accredited investors being unable to sell their shares after the tacking period (usually 2 years for OTC pink sheet companies) expires, since they cannot get the shares custodied at their broker/dealer.

It's not a simple as you think. You are, however correct, in identifying the very tight market conditions for the shares and that it wouldn't take much to get the price of GLUC stock up from here, since the shares are so thinly traded.

The best thing that could happen for GLUC is to see buyers coming in and bidding the price up to $1 or $2. That would dramatically change the dynamics surrounding a reverse split. At a buck, the company would only need to do a 1-for-5 reverse split which is certainly better than a 1-for-10. At $2.50 it looks even better at a 1-for 2 reverse split.

What you fail to understand are the implications and consequences of being a penny stock (defined as less than $5 a share), a non-reporting SEC company and the accompanying difficulties to raise capital.under Rule 15c2-11.

There is more to this than just getting the stock price up to meet the criteria for listing on NASDAQ.